← Back to Clinical Trials
Recruiting NCT07191743

NCT07191743 Functional Assessment in Critically Ill Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07191743
Status Recruiting
Phase
Sponsor Universidade Federal do Rio de Janeiro
Condition Intensive Care Unit Acquired Weakness
Study Type OBSERVATIONAL
Enrollment 186 participants
Start Date 2025-01-01
Primary Completion 2026-07-01

Trial Parameters

Condition Intensive Care Unit Acquired Weakness
Sponsor Universidade Federal do Rio de Janeiro
Study Type OBSERVATIONAL
Phase N/A
Enrollment 186
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-01-01
Completion 2026-07-01

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This longitudinal, prospective observational study aims to evaluate functional status in critically ill adult patients in the Intensive Care Unit using the Chelsea Critical Care Physical Assessment Tool (CPAx). The primary objective is to analyze CPAx score variation as a potential predictor of clinical outcomes, including mortality and duration of mechanical ventilation. Functional assessments will be performed at intensive care unit (ICU) admission and discharge to monitor changes in physical function and to predict adverse clinical outcomes.

Eligibility Criteria

Inclusion Criteria: All adult patients admitted to the Pedro Ernesto University Hospital (HUPE) General ICU over 18 years of age and with an ICU stay greater than or equal to 48 hours will be included. Exclusion Criteria: * Pregnancy * Inability to record the CPAx score within the first 48 hours of ICU admission or on the day of ICU discharge * ICU readmission * Known comorbidities causing generalized weakness, such as neuromuscular or neurological diseases

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology